Chagas disease, caused by Trypanosoma cruzi, is a neglected tropical disease that 26 affects 5-6 million people in endemic areas of the Americas. Presently, chemotherapy 27 relies on two compounds that were proposed as trypanocidal drugs four decades ago: 28 nifurtimox and benznidazole. Both drugs are able to eliminate parasitemia and to avoid 29 seroconversion in infected people when used in the acute phase; however, their use in 30 the chronic phase (the time when the majority of cases are diagnosed) is limited due to 31 their serious side effects. Memantine is a glutamate receptor antagonist in the central 32 nervous system of mammals that has been used for the treatment of Alzheimer's 33 disease. Our group previously reported memantine as a trypanocidal drug that is able to 34 induce apoptosis-like death in T. cruzi. In the present work, we further investigated the 35 effects of memantine on the infection of RAW 264.7 macrophages in vivo (in BALB/c 36 mice). Here, we showed that memantine is able to diminish NO and Ca 2+ entry in both 37 LPS-activated and non-activated cells. These results, together with the fact that 38 memantine was also able to reduce the infection of macrophages, led us to propose that 39 this drug is able to activate a pro-oxidant non-NO-dependent cell defense mechanism.
Effect of memantine on the intracellular amastigote of T. cruzi 151 RAW 264.7 cells (2.5 x 10 4 per well) were cultivated on coverslips in 24-well plates in 152 RPMI medium (10% FCS) and kept at 37 °C. After 24 h, the cells were infected with 153 the trypomastigote form of the Y-strain (2.5 x 10 5 per well) for 4 h. After this time, free 154 parasites were removed by washing twice with PBS; RPMI medium (10% FCS) was 155 replaced, and the cells were treated with different concentrations of memantine (range 156 10 µM to 100 µM) for the following 72 h. Then, the cells were washed with PBS, fixed 157 with 4% paraformaldehyde for 5 min, washed again and treated with Hoechst 33258 for 158 1 min. After washing, the cells were observed by fluorescence microscopy. The infected 159 cells were counted from a sample of 400 randomly chosen cells for determination of the 160 infection rate. The number of amastigotes was also counted to determine the rate of To evaluate the gene expression of inducible nitric oxide synthase, 2 x 10 6 cells per well 178 were cultured for 18 h in 6-well plates in RPMI medium (10% FCS) in the presence of 179 different concentrations of memantine (ranging from 1 to 100 M) or none (control) and 180 were stimulated by 10 g/ml LPS for 18 h. After the incubation time, the supernatant 181 was discarded, and the adhered cells were homogenized with Trizol for RNA extraction 182 (Thermo Fisher Scientific). cDNA was synthetized using the Reverse Transcription Kit 183 SuperScriptII (Thermo Fisher Scientific). qPCR was performed with SYBR Green 184 (Fermentas) for detecting the gene expression levels of iNOS. All reactions were run in 185 triplicate on an Eppendorf RealPlex Real Time PCR System (Eppendorf) with the 186 standard thermal cycling conditions. The runs were normalized with the ACT- gene.
187
The threshold cycle (2 -ΔΔCt ) method of comparative PCR was used for the data analysis. IC 50 of 580 ± 22 µM, 279 ± 2 µM and 257 ± 4.7 µM, respectively (Fig 1A-F) . 239 Once the cytotoxic effect of memantine was evaluated, the RAW 264.7 macrophages 240 were subjugated to infection. For this, the cells were incubated with trypomastigotes for 241 3 h, and then the trypomastigotes remaining in the supernatants were washed out. The 242 infected cells were incubated for 12 h at 37 °C. Then, the culture medium was replaced 243 with culture medium containing different concentrations of memantine (1-100 μM).
244
These treatments were maintained for 72 h. The treatment reduced the number of 245 infected cells at all concentrations tested when compared to the control group (Fig 2) . 246 
Memantine at low (but not at high) concentrations reduces NO
247 production in RAW 264.7 macrophages in vitro 248 Due to the ability of memantine to reduce the number of infected cells in a dose-249 dependent manner, we were interested in checking whether memantine was acting as a 250 trypanocidal compound by inducing macrophage activation. To evaluate the possible 251 effect of memantine on the activation of RAW 264.7 macrophages, we first evaluated 252 their sensitivity to LPS, a well-known macrophage activator (control). For this, the cells 253 were incubated with different concentrations of LPS (1-100 µg/ml) for 24 h, and we 254 considered the ability of the cells to produce NO as a measurement of activation. The
255
NO production increased linearly with the LPS concentration; thus, among the 256 concentrations tested, we chose 10 µg/ml (the maximum concentration tested) for 257 further experiments (S1A Figure) . Next, we performed a time-course experiment to 258 follow the NO production for up to 72 h. We observed a significant increase in the 259 period of 24 h, followed by a plateau that was maintained at 48 and 72 h (S1B Figure) . 260 We then evaluated the effect of memantine treatment (1-100 µM) on nitric oxide (NO) 261 production and iNOS gene expression after 24 h of LPS stimulation. Unexpectedly, 262 memantine treatment showed a reduction in nitrite production at concentrations of 10 263 and 50 μM, as well as in the expression of iNOS mRNA. Interestingly, the 264 concentration of 100 μM did not interfere with NO production, which suggests a dose-265 dependent anti-inflammatory effect (Fig 3A-B) . trypomastigotes were treated for 10 consecutive days. The treated animals showed 289 decreased parasitemia on the days corresponding to the parasitemic peak (7 to 10 d.p.i) 290 by approximately 40% compared to the control group (Fig 4A) . The mouse survival rate 291 was 12.5% compared to the control group survival rate of 7.5% (p = 0.0347) ( Fig 4B) . 292 In summary, memantine treatment decreased parasitemia and extended the survival of 293 infected BALB/c mice.
294
The memantine treatment reduces the parasitic load and increases the 295 inflammatory infiltrate in the heart of infected BALB/c mice 296 To evaluate the effect of memantine on the parasitic load in different tissues from 297 treated mice, we performed real-time PCR to quantify the number of parasites. For this, 298 we obtained DNA (equivalent to 5 ng of tissue DNA (P E /5 ng DNA) from the heart, 299 bladder, intestine, skeletal muscle and liver. Among the evaluated tissues, the heart 300 showed the highest parasitic load (equivalent to 3,427 ± 451 P E /5 ng DNA). The 301 memantine-treated mice showed a significant reduction in the parasitic load in the heart 302 (35.3%) compared to the parasitic load in the values obtained from the control mice 303 (p<0.05) (Fig 5A; S2A -E Figure) . Remarkably, the quantification of the number of 304 amastigote nests per mm², evaluated by microscopy observation, confirmed these data: 305 the hearts from the control mice demonstrated a mean of 2.3 ± 0.35 nests/mm 2 , while 306 the memantine-treated mouse hearts showed a mean of 1.2 ± 0.15 nests/mm 2 (a 307 reduction of approximately 45%, Fig 5B) . Moreover, we also observed that the area of 308 the inflammatory infiltrates (normalized per mm 2 ) was significantly reduced in the 309 treated heart tissues: those from the treated animals showed a mean value of 8.66 ± 4.15 310 inflammatory infiltrate/mm 2 , while those from the control group presented a mean value 311 of 80.53 ± 31.73 inflammatory infiltrate/mm 2 (Fig 5C, as an illustrative example of the 312 amastigote nests and infiltrates in treated mice vs control mice see Fig 5D) . 313 All the obtained data for the parasitic load, amastigote nest and inflammatory infiltrate 314 quantification demonstrate that treatment with memantine reduces the risk of tissue 
